Spots Global Cancer Trial Database for goserelin acetate
Every month we try and update this database with for goserelin acetate cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer | NCT00068601 | Breast Cancer Infertility Menopausal Symp... | cyclophosphamid... goserelin aceta... | 18 Years - 49 Years | SWOG Cancer Research Network | |
| Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer | NCT01120236 | Prostate Adenoc... Recurrent Prost... Stage IV Prosta... | Bicalutamide Cixutumumab Goserelin Aceta... Laboratory Biom... Leuprolide Acet... Pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery) | NCT02742675 | Prostate Cancer | Bicalutamide goserelin aceta... flutamide leuprolide acet... triptorelin Definitive Trea... | 18 Years - 80 Years | Fudan University | |
| Radiation Therapy With or Without Goserelin in Treating Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate Cancer | NCT00423475 | Prostate Cancer | goserelin aceta... adjuvant therap... radiation thera... | 18 Years - 120 Years | UNICANCER | |
| Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery) | NCT02742675 | Prostate Cancer | Bicalutamide goserelin aceta... flutamide leuprolide acet... triptorelin Definitive Trea... | 18 Years - 80 Years | Fudan University | |
| Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer | NCT01120236 | Prostate Adenoc... Recurrent Prost... Stage IV Prosta... | Bicalutamide Cixutumumab Goserelin Aceta... Laboratory Biom... Leuprolide Acet... Pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Pazopanib Hydrochloride After Leuprolide Acetate or Goserelin Acetate in Treating Patients With Relapsed Prostate Cancer | NCT00454571 | Recurrent Prost... | pazopanib hydro... leuprolide acet... goserelin aceta... | 18 Years - | National Cancer Institute (NCI) | |
| Goserelin, Flutamine, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer | NCT00767286 | Prostate Cancer | flutamide goserelin aceta... low-LET cobalt-... low-LET photon ... | 50 Years - | National Cancer Institute (NCI) | |
| Bicalutamide and Goserelin in Treating Patients With Cancer of the Ovary, Fallopian Tube, or Peritoneum | NCT00012090 | Fallopian Tube ... Ovarian Cancer Primary Periton... | bicalutamide goserelin aceta... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases | NCT00081159 | Metastatic Canc... Prostate Cancer | Doxorubicin hyd... Goserelin aceta... Leuprolide acet... Zoledronic acid orchiectomy strontium chlor... | - | M.D. Anderson Cancer Center | |
| Abiraterone Prednisone and Hormonal Therapy Before and During Radiation Therapy in Localized Prostate Cancer | NCT01023061 | Adenocarcinoma ... Stage II Prosta... Stage III Prost... Stage IV Prosta... | abiraterone ace... prednisone leuprolide acet... laboratory biom... external beam r... goserelin aceta... | 18 Years - | University of Washington | |
| Goserelin in Preventing Early Menopause in Premenopausal Women Undergoing Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer | NCT00427245 | Breast Cancer Infertility Menopausal Symp... | cyclophosphamid... goserelin aceta... adjuvant therap... fertility asses... neoadjuvant the... | - | National Cancer Institute (NCI) | |
| Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery | NCT00398489 | Breast Cancer | trastuzumab anastrozole cyclophosphamid... docetaxel epirubicin hydr... goserelin aceta... tamoxifen citra... adjuvant therap... conventional su... neoadjuvant the... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Radiation Therapy With or Without Goserelin and Cyproterone in Treating Patients With Prostate Cancer | NCT00849082 | Prostate Cancer | cyproterone ace... goserelin aceta... radiation thera... | - 79 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Exemestane Plus Goserelin in Treating Premenopausal Women With Metastatic Breast Cancer | NCT00010010 | Breast Cancer | exemestane goserelin aceta... | 18 Years - 120 Years | NYU Langone Health | |
| Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer | NCT03361735 | Prostate Adenoc... | Leuprolide Acet... Goserelin Aceta... Stereotactic Bo... Radium Ra 223 D... Laboratory Biom... Degarelix | 18 Years - | City of Hope Medical Center | |
| Hormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate Cancer | NCT00170157 | Prostate Adenoc... Prostate Carcin... Recurrent Prost... Stage III Prost... Stage IV Prosta... | Bicalutamide Flutamide Goserelin Aceta... Ipilimumab Leuprolide Acet... Pharmacological... | 18 Years - | Mayo Clinic | |
| S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer | NCT01674140 | Breast Cancer | anastrozole everolimus exemestane goserelin aceta... letrozole leuprolide acet... tamoxifen citra... placebo | 18 Years - | SWOG Cancer Research Network | |
| Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer | NCT01368263 | Estrogen Recept... HER2-negative B... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | goserelin aceta... letrozole anastrozole chemotherapy Surgery | 18 Years - | Washington University School of Medicine | |
| Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer | NCT00002580 | Breast Cancer | cyclophosphamid... fluorouracil goserelin aceta... leuprolide acet... methotrexate tamoxifen citra... conventional su... laparoscopic su... oophorectomy radiation thera... | - 70 Years | National Cancer Institute (NCI) | |
| Exemestane Plus Goserelin in Treating Premenopausal Women With Metastatic Breast Cancer | NCT00010010 | Breast Cancer | exemestane goserelin aceta... | 18 Years - 120 Years | NYU Langone Health | |
| SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer | NCT00026377 | Prostate Cancer | bicalutamide flutamide goserelin aceta... leuprolide acet... SU5416 radiation thera... | - | University of Chicago | |
| Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate Cancer | NCT01786265 | Prostate Adenoc... Recurrent Prost... | Abiraterone Ace... Bicalutamide Degarelix Flutamide Goserelin Aceta... Leuprolide Acet... Nilutamide Prednisone | 18 Years - | M.D. Anderson Cancer Center | |
| Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer | NCT01368263 | Estrogen Recept... HER2-negative B... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | goserelin aceta... letrozole anastrozole chemotherapy Surgery | 18 Years - | Washington University School of Medicine | |
| SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer | NCT00002651 | Prostate Cancer | bicalutamide goserelin aceta... clinical observ... | 18 Years - | SWOG Cancer Research Network | |
| Supportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate Cancer | NCT02168062 | Prostate Adenoc... | Behavioral Diet... Counseling Educational Int... Exercise Interv... Goserelin Aceta... Laboratory Biom... Leuprolide Acet... Quality-of-Life... Triptorelin Pam... | - | University of California, San Francisco | |
| Intensity-Modulated Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Prostate Cancer | NCT00653757 | Prostate Cancer | goserelin aceta... leuprolide acet... image-guided ra... intensity-modul... | 19 Years - | Mayo Clinic | |
| Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer | NCT05212857 | Prostate Cancer | Leuprolide acet... Goserelin aceta... Triptorelin ace... Degarelix aceta... Abiraterone ace... Apalutamide Enzalutamide Local treatment... Radiotherapy fo... Radiotherapy fo... | 18 Years - 80 Years | Fudan University | |
| S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer | NCT01674140 | Breast Cancer | anastrozole everolimus exemestane goserelin aceta... letrozole leuprolide acet... tamoxifen citra... placebo | 18 Years - | SWOG Cancer Research Network | |
| Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer | NCT00002580 | Breast Cancer | cyclophosphamid... fluorouracil goserelin aceta... leuprolide acet... methotrexate tamoxifen citra... conventional su... laparoscopic su... oophorectomy radiation thera... | - 70 Years | National Cancer Institute (NCI) | |
| Radiation Therapy for Rising Prostate Specific Antigen (PSA) Post-prostatectomy | NCT00850941 | Prostate Cancer | Questionnaire | 18 Years - | M.D. Anderson Cancer Center | |
| LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Hormone Sensitive Prostate Cancer | NCT02058706 | Adenocarcinoma ... Recurrent Prost... Stage IV Prosta... | enzalutamide bicalutamide orchiectomy leuprolide acet... goserelin aceta... laboratory biom... | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer | NCT00217659 | Breast Cancer | anastrozole goserelin aceta... | 18 Years - | SWOG Cancer Research Network | |
| Bicalutamide and Goserelin in Treating Patients With Cancer of the Ovary, Fallopian Tube, or Peritoneum | NCT00012090 | Fallopian Tube ... Ovarian Cancer Primary Periton... | bicalutamide goserelin aceta... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Combination Chemotherapy in Treating Women With Breast Cancer | NCT00047099 | Breast Cancer | cyclophosphamid... docetaxel epirubicin hydr... fluorouracil goserelin aceta... tamoxifen citra... adjuvant therap... radiation thera... | 18 Years - 70 Years | National Cancer Institute (NCI) | |
| Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer | NCT00589472 | Prostate Adenoc... Stage I Prostat... Stage IIA Prost... Stage IIB Prost... Stage III Prost... | Bicalutamide Goserelin Aceta... Laboratory Biom... Leuprolide Acet... Therapeutic Con... Vorinostat | 19 Years - | National Cancer Institute (NCI) | |
| Risk and Clinical Benefit of Chemotherapy and Intensive Endocrine Therapy for Luminal B1 Early-stage Breast Cancer | NCT03373708 | Breast Cancer Chemotherapy Endocrine Breas... | Epirubicin Cyclophosphamid... Docetaxel Goserelin aceta... Tamoxifen Letrozole | 18 Years - 70 Years | Shandong Cancer Hospital and Institute | |
| Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast Cancer | NCT00053911 | Breast Cancer | anastrozole cyclophosphamid... docetaxel epirubicin hydr... fluorouracil goserelin aceta... tamoxifen citra... adjuvant therap... | 18 Years - 65 Years | UNICANCER | |
| Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer | NCT01368263 | Estrogen Recept... HER2-negative B... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | goserelin aceta... letrozole anastrozole chemotherapy Surgery | 18 Years - | Washington University School of Medicine | |
| Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer | NCT00002582 | Breast Cancer | CMF regimen cyclophosphamid... doxorubicin hyd... fluorouracil goserelin aceta... leuprolide acet... methotrexate tamoxifen citra... oophorectomy radiation thera... | - | National Cancer Institute (NCI) | |
| Goserelin, Flutamine, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer | NCT00767286 | Prostate Cancer | flutamide goserelin aceta... low-LET cobalt-... low-LET photon ... | 50 Years - | National Cancer Institute (NCI) | |
| Protection of Ovarian Function With Goserelin Acetate in Premenopausal Early Breast Cancer Patients With Chemotherapy | NCT00888082 | Breast Cancer Ovarian Functio... | Goserelin aceta... | 18 Years - 45 Years | AstraZeneca | |
| Study of Zoladex Given Every 12 Weeks Versus Given Every Month in Advanced Breast Cancer (ABC) Pre-menopausal Women | NCT00322348 | Advanced Breast... | Goserelin aceta... Goserelin aceta... | 18 Years - | AstraZeneca | |
| Leuprolide Acetate or Goserelin Acetate With or Without Vismodegib Followed by Surgery in Treating Patients With Locally Advanced Prostate Cancer | NCT01163084 | Prostate Adenoc... Stage IIA Prost... Stage IIB Prost... | Goserelin Aceta... Laboratory Biom... Leuprolide Acet... Vismodegib | 18 Years - | National Cancer Institute (NCI) | |
| Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer | NCT00589472 | Prostate Adenoc... Stage I Prostat... Stage IIA Prost... Stage IIB Prost... Stage III Prost... | Bicalutamide Goserelin Aceta... Laboratory Biom... Leuprolide Acet... Therapeutic Con... Vorinostat | 19 Years - | National Cancer Institute (NCI) | |
| A Degarelix Trial in Patients With Prostate Cancer | NCT01242748 | Prostate Cancer | Degarelix Goserelin aceta... | 18 Years - | Ferring Pharmaceuticals | |
| Hormone Therapy and Temsirolimus in Treating Patients With Relapsed Prostate Cancer | NCT00512668 | Adenocarcinoma ... Recurrent Prost... | leuprolide acet... goserelin aceta... bicalutamide nilutamide flutamide temsirolimus laboratory biom... | - | National Cancer Institute (NCI) | |
| Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery | NCT00398489 | Breast Cancer | trastuzumab anastrozole cyclophosphamid... docetaxel epirubicin hydr... goserelin aceta... tamoxifen citra... adjuvant therap... conventional su... neoadjuvant the... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer | NCT00068601 | Breast Cancer Infertility Menopausal Symp... | cyclophosphamid... goserelin aceta... | 18 Years - 49 Years | SWOG Cancer Research Network | |
| Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer | NCT00104715 | Prostate Cancer | antiandrogen th... docetaxel goserelin aceta... orchiectomy | 18 Years - 120 Years | UNICANCER | |
| Intensity-Modulated Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Prostate Cancer | NCT00653757 | Prostate Cancer | goserelin aceta... leuprolide acet... image-guided ra... intensity-modul... | 19 Years - | Mayo Clinic | |
| To Compare ZOLADEX 10.8 mg With ZOLADEX 3.6mg in Chinese Pre-menopausal ER+ HER2- Early Breast Cancer. | NCT03658213 | Breast Cancer | ZOLADEX 10.8 mg ZOLADEX 3.6mg | 18 Years - 59 Years | AstraZeneca | |
| Pilot Study to Evaluate the Effects of a Generic Goserelin Acetate in Patients With Prostate Cancer | NCT04060043 | Prostate Cancer | Goserelin Aceta... | 18 Years - | CMX Research | |
| Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer | NCT00348998 | Prostate Cancer | bevacizumab bicalutamide goserelin aceta... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer | NCT00002460 | Breast Cancer | goserelin aceta... tamoxifen citra... ablative endocr... oophorectomy | - 49 Years | National Cancer Institute (NCI) | |
| Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer | NCT00002881 | Prostate Cancer | flutamide goserelin aceta... leuprolide acet... suramin therapeutic hyd... orchiectomy | 18 Years - | National Cancer Institute (NCI) | |
| Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer | NCT03361735 | Prostate Adenoc... | Leuprolide Acet... Goserelin Aceta... Stereotactic Bo... Radium Ra 223 D... Laboratory Biom... Degarelix | 18 Years - | City of Hope Medical Center | |
| Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer | NCT00003394 | Prostate Cancer | carboplatin endocrine-modul... estramustine ph... goserelin aceta... leuprolide acet... paclitaxel | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate Cancer | NCT00014586 | Prostate Cancer | bicalutamide goserelin aceta... orchiectomy | - 80 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer | NCT04734730 | Castration-Sens... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... | Abiraterone Ace... Bicalutamide Degarelix Goserelin Aceta... Leuprolide Acet... Prednisone Questionnaire A... Talazoparib | 18 Years - | City of Hope Medical Center | |
| Pilot Study to Evaluate the Effects of a Generic Goserelin Acetate in Patients With Prostate Cancer | NCT04060043 | Prostate Cancer | Goserelin Aceta... | 18 Years - | CMX Research | |
| Hormone Therapy and Intensity-Modulated Radiation Therapy in Treating Patients With Metastatic Prostate Cancer | NCT00544830 | PSA Level Great... Stage IV Prosta... | Bicalutamide Goserelin Aceta... Intensity-Modul... Laboratory Biom... Leuprolide Acet... | 18 Years - | City of Hope Medical Center | |
| Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer | NCT04734730 | Castration-Sens... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... | Abiraterone Ace... Bicalutamide Degarelix Goserelin Aceta... Leuprolide Acet... Prednisone Questionnaire A... Talazoparib | 18 Years - | City of Hope Medical Center | |
| Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging | NCT04423211 | Biochemically R... Metastatic Pros... Prostate Adenoc... Stage IVB Prost... | 3-Dimensional C... Apalutamide Computed Tomogr... Degarelix External Beam R... Fluciclovine F1... Goserelin Aceta... Intensity-Modul... Intensity-Modul... Leuprolide Acet... Magnetic Resona... Positron Emissi... Quality-of-Life... Questionnaire A... Relugolix Stereotactic Bo... Triptorelin Volume Modulate... | 18 Years - | Eastern Cooperative Oncology Group | |
| Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse | NCT00055731 | Prostate Cancer | bicalutamide Goserelin Aceta... docetaxel Estramustine ph... acetylsalicylic... conventional su... radiation thera... | 0 Years - 79 Years | UNICANCER | |
| Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer | NCT00003394 | Prostate Cancer | carboplatin endocrine-modul... estramustine ph... goserelin aceta... leuprolide acet... paclitaxel | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer | NCT00067015 | Prostate Cancer | bicalutamide goserelin aceta... assessment of t... quality-of-life... radiation thera... | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Immediate Versus Deferred Androgen Deprivation Therapy,Goserelin for Recurrent Prostate Cancer After Radical Radiotherapy | NCT00439751 | Prostate Cancer | Goserelin Aceta... | 18 Years - | Ontario Clinical Oncology Group (OCOG) | |
| Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer | NCT03678025 | Castration Leve... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... | Abiraterone Bicalutamide Degarelix Docetaxel Flutamide Goserelin Aceta... Histrelin Aceta... Leuprolide Acet... Nilutamide Orchiectomy Prednisone Quality-of-Life... Radiation Thera... Radical Prostat... Triptorelin | 18 Years - | SWOG Cancer Research Network | |
| Androgen Deprivation Therapy (ADT) and Pembrolizumab for Advanced Stage Androgen Receptor-positive Salivary Gland Carcinoma | NCT03942653 | Salivary Gland ... | Goserelin Aceta... Pembrolizumab | 18 Years - | Big Ten Cancer Research Consortium | |
| Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate Cancer | NCT00014586 | Prostate Cancer | bicalutamide goserelin aceta... orchiectomy | - 80 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| To Compare ZOLADEX 10.8 mg With ZOLADEX 3.6mg in Chinese Pre-menopausal ER+ HER2- Early Breast Cancer. | NCT03658213 | Breast Cancer | ZOLADEX 10.8 mg ZOLADEX 3.6mg | 18 Years - 59 Years | AstraZeneca | |
| Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer | NCT02278185 | Adenocarcinoma ... Recurrent Prost... Stage III Prost... Stage IV Prosta... | Enzalutamide leuprolide acet... goserelin aceta... histrelin aceta... triptorelin degarelix | 19 Years - | University of Colorado, Denver | |
| Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer | NCT00589472 | Prostate Adenoc... Stage I Prostat... Stage IIA Prost... Stage IIB Prost... Stage III Prost... | Bicalutamide Goserelin Aceta... Laboratory Biom... Leuprolide Acet... Therapeutic Con... Vorinostat | 19 Years - | National Cancer Institute (NCI) | |
| LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Hormone Sensitive Prostate Cancer | NCT02058706 | Adenocarcinoma ... Recurrent Prost... Stage IV Prosta... | enzalutamide bicalutamide orchiectomy leuprolide acet... goserelin aceta... laboratory biom... | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer | NCT00104715 | Prostate Cancer | antiandrogen th... docetaxel goserelin aceta... orchiectomy | 18 Years - 120 Years | UNICANCER | |
| A Trial of Degarelix in Patients With Prostate Cancer | NCT00946920 | Prostate Cancer | Degarelix Goserelin aceta... | 18 Years - | Ferring Pharmaceuticals | |
| Immediate Versus Deferred Androgen Deprivation Therapy,Goserelin for Recurrent Prostate Cancer After Radical Radiotherapy | NCT00439751 | Prostate Cancer | Goserelin Aceta... | 18 Years - | Ontario Clinical Oncology Group (OCOG) | |
| High-Dose Brachytherapy in Treating Patients With Prostate Cancer | NCT02346253 | Prostate Adenoc... Stage I Prostat... Stage IIA Prost... Stage IIB Prost... Stage III Prost... | Internal Radiat... Bicalutamide Leuprolide Acet... Goserelin Aceta... Triptorelin Pam... Degarelix Laboratory Biom... Quality-of-Life... | - | Stanford University | |
| Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate Cancer | NCT00500110 | Prostate Cancer | Docetaxel Imatinib Mesyla... Leuprolide Goserelin Aceta... | - | M.D. Anderson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
